中文

R&D 

Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address:8888 Lvyou Road, Jinan, Shandong 250104, CHINA

PRODUCTS

MANUFACTURING

NEWS

CONTACT US

ABOUT US

Ondansetron Hcl for Injection of Qilu was approved by USFDA

Classification:
Company news
Author:
Source:
Release time:
2014/11/20 00:00
Page view
[Abstract]:
Ondansetron Hcl for Injection, manufactured by Qilu Pharmaceutical was approved by USFDA

 Recently, Ondansetron Hcl for Injection, manufactured by Qilu Pharmaceutical was approved by USFDA which means that it has been permitted to be sold in USA.

    As early as 1994, Qilu firstly launched Ondansetron Hcl in China. Since then, its market share has always maintained the leading position. Following after various FDFs and APIs of the company has been exported to EU, USA, Australia and many other countries, the approval is another significant breakthrough of FDF in US market. That means the capability of R&D, products manufacturing and quality control of Qilu has been highly recognized by international market.

NEWS